Geneva Partners’s Nutrien NTR Stock Holding History

Geneva Partners’s Portfolio NTR Stock Details NTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,950	Closed	-$823K	–	108
2021 Q4	$823K	Buy	+10,950	New	+$766K	0.39%	53

Other funds holding NTR

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Geneva Partners's NTR Position: Q1 2022 in Review

Geneva Partners sold out of Nutrien (NTR) in Q1 2022, closing a stake of 10,950 shares — an estimated $823K sold.

Geneva Partners first reported a position in NTR in Q4 2021 and held it in 1 quarter. The position peaked at $823K in Q4 2021. 756 funds tracked by Wall St. Rank hold NTR as of Q1 2022.

Geneva Partners reported no remaining Nutrien position as of Q1 2022 after selling out during the quarter.
Geneva Partners sold 10,950 Nutrien shares in Q1 2022, an estimated $823K.
Geneva Partners first reported a position in Nutrien in Q4 2021 and held it in 1 quarter.
Geneva Partners's Nutrien position peaked at $823K in Q4 2021.
756 funds tracked by Wall St. Rank held Nutrien as of Q1 2022.

Based on Geneva Partners's 13F filing for Q1 2022, filed 3 May 2022.